Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Little Rock
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Little Rock, AR

Studies commonly pay $75 to $4,500 per completed study

505 clinical trials are currently recruiting participants within 30 miles of Little Rock. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

505studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Little Rock right now

Top 25 of 505 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Little Rock, Arkansas (4.1 mi) · Sponsor: AstraZeneca

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Medical Investigations — Little Rock, Arkansas (4.1 mi) · Sponsor: Medtronic MiniMed, Inc.

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Malignant Solid Neoplasm N/A Interventional 1,020 participants sought
CARTI Cancer Center — Little Rock, Arkansas (4.1 mi) · Sponsor: SWOG Cancer Research Network

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: SWOG Cancer Research Network

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome N/A Interventional 1,040 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: University of Calgary

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Little Rock, Arkansas (4.1 mi) · Sponsor: AstraZeneca

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease Phase 2 Interventional 150 participants sought
University of Arkansas for Medical Sciences (Site #208) — Little Rock, Arkansas (4.1 mi) · Sponsor: Appello Pharmaceuticals, Inc.

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Lymphatic Malformation Phase 2 Interventional 38 participants sought
Arkansas Children's Hospital/UAMS — Little Rock, Arkansas (4.1 mi) · Sponsor: Protara Therapeutics

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 641 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi) · Sponsor: Janssen Research & Development, LLC

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Preferred Research Partners /ID# 270389 — Little Rock, Arkansas (4.1 mi) · Sponsor: AbbVie

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Endocervical Cancer N/A Interventional 20 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: University of Arkansas

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Platinum-resistant Ovarian Cancer, Testicular Cancer Phase 1 Interventional 156 participants sought
University of Arkansas Winthrop P. Rockefeller Cancer Institute — Little Rock, Arkansas (4.1 mi) · Sponsor: Context Therapeutics Inc.

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi) · Sponsor: Duke University

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis, Atopic Phase 2 Interventional 280 participants sought
Dermatology Trial Associates, Inc — Bryant, Arkansas (11.7 mi) · Sponsor: Apollo Therapeutics Ltd

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

Neurogenic Detrusor Overactivity Phase 2, Phase 3 Interventional 71 participants sought
Arkansas Childrens Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: Urovant Sciences GmbH

A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

Epilepsy, Generalized, Epilepsy, Absence Phase 2 Interventional 12 participants sought
Clinical Trials, Inc. (CTI) — Little Rock, Arkansas (4.1 mi) · Sponsor: NeuroPro Therapeutics, Inc.

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

Carotid Artery Calcification, Carotid Artery Diseases N/A Interventional 185 participants sought
Arkansas Heart Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: Shockwave Medical, Inc.

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Pharmacokinetics After Oral Intake Phase 1 Interventional 12 participants sought
Medical facility — Little Rock, Arkansas (4.1 mi) · Sponsor: Iterum Therapeutics, International Limited

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi) · Sponsor: Janssen Research & Development, LLC

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi) · Sponsor: Janssen Research & Development, LLC
Actively enrolling

Studies you may be able to join near Little Rock

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Little Rock

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Baptist Health Center for Clinical Research

★ 4.4
9601 Baptist Health Dr #310, Little Rock, AR 72205
(501) 623-9930
"Great facility, friendly staff, and they genuinely care about treating people even beyond the expectations of their clinical trials!"
— Sam Caskanett, 5★

Applied Research Center and Wellness Clinic

★ 4.6
1701 Aldersgate Rd #1, Little Rock, AR 72205
(501) 954-7822

Woodland International Research

★ 4.5
910 Autumn Rd, Little Rock, AR 72211
(501) 221-8681
"I wish I could give 0 stars for this place."
— Laura Milam, 1★

Pillar Clinical Research, Little Rock, Arkansas

★ 5.0
19 Remington Dr, Little Rock, AR 72204
(501) 307-1919
"This place is absolutely beyond amazing especially the great staffs! I would recommend this to anyone!"
— Jay, 5★

B.G. Clinical Research Center, LLC

9601 Baptist Health Dr #240, Little Rock, AR 72205
(501) 725-5834

Clinical Trials Inc

2 Lile Ct #100, Little Rock, AR 72205
(501) 227-5061

Lynn Institute of the Ozarks

★ 4.0
6209 W 12th St STE B, Little Rock, AR 72204
(501) 975-2000
"I am taking part in one of their double blind medical research trials. The staff and trial coordinator seem quite competent to me."
— linda chambers, 5★

Preferred Research Partners

★ 4.8
11219 Financial Centre Pkwy, Little Rock, AR 72211
(501) 553-9987

Pillar Clinical Research

11700 Kanis Rd Ste 2, Little Rock, AR 72211
(501) 221-1941

Clinical trials in Little Rock: what's recruiting

The Little Rock area currently has 505 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Little Rock, the most active research areas are:

  • Cancer & Oncology7 studies
  • Brain & Mental Health2 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Little Rock, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Little Rock

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Little Rock participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Little Rock pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Little Rock?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Little Rock safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Little Rock, AR?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Little Rock typically complete one or two studies per year.

Paid clinical trials near Little Rock

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of AR

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts